Moreno 2016.

Methods	Randomised clinical trial, Belgium
Participants	136 hospitalised adults with severe alcoholic hepatitis, at nutritional risk by trialists Male:Female = 86:50 Mean age = 50 years Exclusion criteria: Not stated
Interventions	Experimental group: Intensive enteral nutrition: Enteral nutrition was given using a feeding tube for 14 days and participants received Fresubin HP Energy (1.5 kcal/ml, 7.5 g prot/100 ml) as follows: 1 L/day if body weight < 60 kgs, 1.5 L if body weight was between 60 and 90 kgs, 2 L if body weight was > 90 kgs. (n = 68) Control group: Treatment as usual ("conventional nutrition")(n = 68) Co‐interventions: Methylprednisolone
Outcomes	6 months survival
Study dates	Feburary 2010 to February 2013
Notes	We did not contact the authors since the trial was included late in the writing phase.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not described
Allocation concealment (selection bias)	Low risk	Sealed opaque envelopes
Blinding of participants and personnel (performance bias) All outcomes	High risk	Participants were not blinded.
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not described
Incomplete outcome data (attrition bias) All outcomes	Low risk	There was under 5% with missing data
Selective reporting (reporting bias)	Low risk	A protocol could not be obtain but the trial reported all‐cause mortality and serious adverse events (NCT01801332, published after completion).
For‐profit bias	High risk	Several of the authors received grants for trials which might have conflict of interest (Abbvie, Novartis).
Other bias	Low risk	The trial appeared to be free of other components that could put it at risk of bias.